Krystal Biotech Receives $700K Equity-Based Award to Develop Gene Therapy for DEB – Epidermolysis Bullosa News
Epidermolysis Bullosa News |
Krystal Biotech Receives $700K Equity-Based Award to Develop Gene Therapy for DEB
Epidermolysis Bullosa News “Our lead product candidate KB103, based on our proprietary gene therapy platform, is designed to be an ‘off-the-shelf’ topical product to treat dystrophic epidermolysis bullosa (DEB). We currently expect to file an Investigational New Drug Application … |
Northwest Herald |
Baby gene therapy study offers hope for fatal muscle disease
Northwest Herald WASHINGTON – A first attempt at gene therapy for a disease that leaves babies unable to move, swallow and, eventually, breathe has extended the tots’ lives, and some began to roll over, sit and stand on their own, researchers reported last week. Only … Study offers hope for fatal muscle diseaseIndiana Gazette |
GeekWire |
Immunotherapy is safe for those with HIV, study says, opening new treatments to patients in need
GeekWire The finding is important because HIV/AIDS patients have been excluded from the early trials that test immunotherapy treatments, largely because the treatments use the body’s immune system to fight cancer. Because HIV/AIDS patients have a compromised … For cancer patients with HIV, immunotherapy appears safeMedical Xpress |